SEATTLE, WA--(Marketwired - Oct 27, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated
to legal cannabis, announces the publication of an article discussing Medical Marijuana Inc.'s (OTC PINK: MJNA) pioneering efforts to get hemp-based
cannabidiol (CBD) products approved for use internationally, and particularly the recent Brazilian court ruling ordering the
government to subsidize payments for its products.
The global hemp industry is projected to surpass $1 billion in revenue next year, according to the Hemp Business Journal, and
hemp-based cannabidiol (CBD) is among the fastest growing segments with a 53% compound annual growth rate over the past several
years.
Medical Marijuana Inc.'s 100%-owned HempMeds® subsidiary sells a full-spectrum, complete CBD hemp oil called Real Scientific Hemp Oil, or RSHO™. Starting with hemp grown in
Northern Europe, the company produces the highest quality natural hemp oil in the industry with 10% to 30% CBD content. The
tremendous success in growing this business has made it the second largest asset on MJNA's balance sheet at $140 million.
Brazil Subsidizes RSHO™ for Citizen
Medical Marijuana Inc. recently announced that Brazilian Federal Judge Rogerio Favreto ordered the government to
subsidize payments for RSHO™ for one of its citizens. This was the second recent case where a federal judge has ordered the
government to subsidize payments for CBD in Santa Catarina, saying that CBD should be covered as a prescription pharmaceutical
given its proven medical benefits.
According to an account by a
Brazilian newspaper:
"The trader appealed to the court, arguing that the use of the drug is essential, that efficacy is proven in such cases and
that the right to health is fundamental and guaranteed by the Constitution. The court's rapporteur, federal judge Rogerio
Favreto, stated in his vote that the interference of the judiciary in drug applications, even if it is an exception, should occur
if the patient's need is proven. The judge pointed out that in the case under analysis the urgency is evident and has been proven
by medical expertise."
Medical Marijuana Inc.'s RSHO™ has been a go-to hemp-based CBD product around the world. With the goal of bringing hemp oil to
the masses, the company has sought out to make it easier for patients to petition governments while developing a product that
meets the strictest standards to limit tetrahydrocannabinol (THC) content.
"We continue to be impressed and humbled by the amazing, historic gestures by the judicial system and federal government
regulators in Brazil acting in the best interests of the health and wellness of the Brazilian people," said Medical Marijuana,
Inc. CEO Dr. Stuart Titus. "This amazing progress in the Brazilian courts reaffirms our mission to keep educating the world about
the beneficial nature of hemp-based cannabidiol (CBD) products such as RSHO™."
Expanding Global Presence
Medical Marijuana Inc. has been making progress in marketing RSHO™ around the world, where it has been embraced by
patients, doctors, and citizens.
The first breakthrough came in Brazil where the family of a little girl fought for the right to import RSHO™. After taking the
case to the nation's courts, it was declared "inhumane" to keep hemp oil from the girl and HempMeds® began shipping RSHO™
directly to patients in Brazil where it is now wholly subsidized through the nation's healthcare system as a prescription
medication. HempMeds® Brazil was setup to help patients navigate the complex regulations.
A similar situation unfolded in Mexico where Raul Elizalde discovered CBD hemp oil and its potential benefits for his
daughter. He created the Por Grace Foundation and teamed up with HempMeds® to create awareness among patients. The nation's
health authority, COFEPRIS, ultimately approved the use of CBD under the condition that it has no THC content. To meet these
requirements, the company developed THC-free RSHO-X™ and setup HempMeds Mexico.
The company has since expanded its product reach into several other regions and countries around the world, including Puerto
Rico and parts of South America. In addition, the company has established a wholesale division that sells high quality hemp oil
to third-party product manufacturers and marketers looking to expand their product lines.
For more information, visit the company's website or
CannabisFN's company profile.
Please follow the link to read the full article: http://www.cannabisfn.com/medical-marijuana-inc-continues-expand-international-reach/
Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help
marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana
companies and brands in the US and Canada rely on CFN Media to grow and succeed.
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to
source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial
spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses,
while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit http://www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s video statement, click here.
Shareholders are also encouraged to visit the Medical
Marijuana, Inc. Shop for discounted products.
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking
statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any
future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media
and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to
provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a
position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific
investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form
of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full
disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.